The Biomarkers Market research report provides valuable insights by analyzing market trends and market scenarios over a defined period. It also presents manufacturing details like sales, volume, revenue, price, and gross margin. Furthermore, the import-export analysis, and pricing analysis are also included in the report to understand the product demand and service. Finally, it also provides end-user application analysis, which delivers revenue, and growth percentage of the product across the different applications. Moreover, the report also highlights the covid 19 impacts on the Biomarkers Market and guides in overcoming the challenges during this pandemic.
Biomarkers Market by Product (Consumable, Service), Type (Safety, Efficacy, Validation), Disease (Cancer (Solid & Liquid Biopsy), Neurological), Application (Diagnostics, Drug Discovery & Development, Personalized Medicine), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Market Overview
The global biomarkers market size was valued at USD 43.1 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2021 to 2028.
Get a Sample Copy of the Report: https://www.delvens.com/get-free-sample/biomarkers-market-trends-forecast-till-2028
Diagnostic biomarkers are minimally or non-invasive tools. Biomarkers, integrated with key imaging and data management technologies, is meeting the market expectations; however, has set backs too. Biomarkers are used in imaging technology to provide clear imaging of oncology tumours and other problems and also eliminate chance of radiation exposure during imaging through CT scan and MRI scan.
The growing importance of companion diagnostics, increasing prevalence of cancer worldwide, increasing funds & grants for biomarker research, and continuous product innovations are some of the factors that have supported long-term expansion for Biomarkers Market.
Many biomarkers are also playing an important role in the diagnosis of COVID-19. Biomarkers such as C-reactive protein, serum amyloid A, interleukin-6, lactate dehydrogenase, neutrophil-to-lymphocyte ratio, D-dimer, cardiac troponin, renal biomarkers, lymphocytes and platelet count. These markers showed significantly higher levels in patients with severe complications of COVID-19 infection compared to their non-severe counterparts.
Regional Analysis
North America accounted for the largest share of the market. The large share of this region can be attributed to the growing use of biomarkers in personalized medicine, various growth strategies adopted by key players with established pharmaceutical companies in this region, and a higher adoption rate of biomarkers for disease diagnostics, majorly in cancer diagnosis.
Key Players
· F. Hoffmann-La Roche Ltd.
· Thermo Fisher Scientific Inc.
· Abbott Laboratories
· QIAGEN N.V.
· PerkinElmer, Inc.
· Merck KGaA
· Bio-Rad Laboratories, Inc.
· Enzo Biochem, Inc.
· Charles River Laboratories International, Inc.
· Eurofins Scientific
To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/biomarkers-market-trends-forecast-till-2028
Recent Developments
· In April 2021, F. Hoffmann-La Roche Ltd. (Switzerland) launched two cardiac biomarker tests for high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers support cardiovascular disease management and can help clinicians diagnose heart attacks and manage heart failure better.
· In May 2021, QIAGEN N.V. (Netherlands) launched the first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit, to identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options in lung cancer.
Reasons to Acquire
· Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
· Gain authentic and granular data access for Biomarkers Market so as to understand the trends and the factors involved behind changing market situations
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Table of Contents
Biomarkers Market is segmented into product & services, type, application, disease indication and region.
On the basis of Product
· Consumables
· Services
· Software
On the basis of Type
· Safety Biomarkers
· Efficacy Biomarkers
· Predictive Biomarkers
· Surrogate Biomarkers
· Pharmacodynamics Biomarkers
· Prognostic Biomarkers
· Validation Biomarkers
On the basis of Application
· Diagnostics
· Drug Discovery & Development
· Personalized Medicine
· Disease Risk Assessment
On the basis of Disease Infection
· Infectious Diseases
· Immune Disorders
· Neurological Disorders
· Cardiovascular Disorders
· Cancer by test type
On the basis of Region
· Asia Pacific
· North America
· Europe
· South America
· Middle East & Africa
Get Direct Order of this Report: https://www.delvens.com/checkout/biomarkers-market-trends-forecast-till-2028
Browse Related Reports:
Genetic Testing Market – Trends Forecast Till 2030
Cardiac Safety Services Market – Trends Forecast Till 2030
Cardiovascular Drugs Market – Trends Forecast Till 2030
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports, and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on the country, regional, and global business environment. We have a database for more than 45 industries globally in more than 115+ major countries.
Delvens database assists clients by providing in-depth information on crucial business decisions. Delvens offers significant facts and figures across various industries: Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, and Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)